REGN ▼ -1.3% - Regeneron Pharmaceuticals, Inc. $REGN - Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing 18-NOV-2026 06:03 PM ET